Fair assessment edcpf. Yes, the timing of these PRs is suspect, in my opinion. The ebola PR was released at the height of the ebola media craze and just a few days before ASM. It was so important to Peregrine that communication at the ASM was muted. Also, I have yet to see any link with Peregrine attending the New Orleans conference two weeks after the PR was released. So, it makes me question the intentions of management regarding the ebola PR.
I'll give you the PS-targeting timeline working in immunotherapy. Although, you would have to agree, immunotherapy has been the hot trend in oncology the past few years - which just happens to be when the new MO was "discovered" by Peregrine.
For various reasons, I contend SK is not qualified to be CEO. Lab Director, yes. My biggest concern with him has been a lack of urgency and lack of follow up to his promises. While Peregrine holds the best kept secret in biotech, other companies and applications are making strides in the field. As has been posted, this is a horse race, I question if the current management has the horse power to make it to the finish line on time. A partnership would quell those doubts, but does King have the fortitude to bring the partnership to fruition?
News 
Market Data 
Discover 
AI
